Z Zhang1, R N DuBois. 1. Division of Gastroenterology, Department of Medicine and Cell Biology, Vanderbilt University Medical Center, Veterans Affairs Medical Center, Nashville, Tennessee, USA.
Abstract
BACKGROUND & AIMS: Many reports indicate that nonsteroidal anti-inflammatory drugs (NSAIDs) have antineoplastic effects, but the precise molecular mechanism(s) responsible are unclear. We evaluated the effect of cyclooxygenase (COX) inhibitors (NSAIDs) on human colon carcinoma cells (HCA-7) and identified several genes that are regulated after treatment with NS-398, a selective COX-2 inhibitor. METHODS: Differential display polymerase chain reaction cloning techniques were used to identify genes regulated by treatment with NSAIDs and selective COX-2 inhibitors. RESULTS: A prostate apoptosis response 4 (Par-4) gene was up-regulated after NSAID treatment. Par-4 was first isolated from prostate carcinoma cells undergoing apoptosis, and expression of Par-4 sensitized cancer cells to apoptotic stimuli. Par-4 levels were increased in cells treated with COX inhibitors such as NS-398, nimesulide, SC-58125, and sulindac sulfide. Treatment of HCA-7 cells with these agents also induced apoptotic cell death. CONCLUSIONS: The results suggest that regulation of Par-4 contributes to the proapoptotic effects of high-dose COX inhibitors (NSAIDs) by serving as a downstream mediator leading to initiation of programmed cell death.
BACKGROUND & AIMS: Many reports indicate that nonsteroidal anti-inflammatory drugs (NSAIDs) have antineoplastic effects, but the precise molecular mechanism(s) responsible are unclear. We evaluated the effect of cyclooxygenase (COX) inhibitors (NSAIDs) on humancolon carcinoma cells (HCA-7) and identified several genes that are regulated after treatment with NS-398, a selective COX-2 inhibitor. METHODS: Differential display polymerase chain reaction cloning techniques were used to identify genes regulated by treatment with NSAIDs and selective COX-2 inhibitors. RESULTS: A prostate apoptosis response 4 (Par-4) gene was up-regulated after NSAID treatment. Par-4 was first isolated from prostate carcinoma cells undergoing apoptosis, and expression of Par-4 sensitized cancer cells to apoptotic stimuli. Par-4 levels were increased in cells treated with COX inhibitors such as NS-398, nimesulide, SC-58125, and sulindac sulfide. Treatment of HCA-7 cells with these agents also induced apoptotic cell death. CONCLUSIONS: The results suggest that regulation of Par-4 contributes to the proapoptotic effects of high-dose COX inhibitors (NSAIDs) by serving as a downstream mediator leading to initiation of programmed cell death.
Authors: Kaushik Dutta; Frank A Engler; Levaughn Cotton; Andrei Alexandrov; Gurrinder S Bedi; Jennifer Colquhoun; Steven M Pascal Journal: Protein Sci Date: 2003-02 Impact factor: 6.725
Authors: Yuyi Wang; Chi Du; Nan Zhang; Mei Li; Yanyang Liu; Maoyuan Zhao; Feng Wang; Feng Luo Journal: Oncol Lett Date: 2018-02-14 Impact factor: 2.967
Authors: Bi-Dar Wang; Christina Leah B Kline; Danielle M Pastor; Thomas L Olson; Bryan Frank; Truong Luu; Arun K Sharma; Gavin Robertson; Matthew T Weirauch; Steven R Patierno; Joshua M Stuart; Rosalyn B Irby; Norman H Lee Journal: Mol Cancer Date: 2010-04-30 Impact factor: 27.401
Authors: Isabel Garcia-Cao; María José Lafuente; Luis M Criado; María Teresa Diaz-Meco; Manuel Serrano; Jorge Moscat Journal: EMBO Rep Date: 2003-03 Impact factor: 8.807